Patents by Inventor Ingie Hong

Ingie Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATING SYNGAP
    Publication number: 20230374510
    Abstract: Disclosed are methods and compositions for treating a neurodevelopmental disorder in a subject in need thereof. In some aspects, the method includes administering an effective amount of an agent, wherein administering the agent modulates expression of one or more isoforms of synaptic GTPase-activating protein (SynGAP).
    Type: Application
    Filed: March 17, 2023
    Publication date: November 23, 2023
    Inventors: Richard Huganir, Ingie Hong, Yoichi Araki
  • Modulating SYNGAP
    Patent number: 11618900
    Abstract: Disclosed are methods and compositions for treating a neurodevelopmental disorder in a subject in need thereof. In some aspects, the method includes administering an effective amount of an agent, wherein administering the agent modulates expression of one or more isoforms of synaptic GTPase-activating protein (SynGAP).
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: April 4, 2023
    Assignee: The Johns Hopkins University
    Inventors: Richard Huganir, Ingie Hong, Yoichi Araki
  • MODULATING SYNGAP
    Publication number: 20210180062
    Abstract: Disclosed are methods and compositions for treating a neurodevelopmental disorder in a subject in need thereof. In some aspects, the method includes administering an effective amount of an agent, wherein administering the agent modulates expression of one or more isoforms of synaptic GTPase-activating protein (SynGAP).
    Type: Application
    Filed: October 30, 2020
    Publication date: June 17, 2021
    Inventors: Richard Huganir, Ingie Hong, Yoichi Araki
  • Pharmaceutical composition containing GLUR2-lacking AMPAR antagonist for preventing or treating psychiatric illnesses
    Patent number: 8835503
    Abstract: A pharmaceutical composition, comprising a GluR2-lacking AMPAR antagonist as an active ingredient, is effective for preventing or treating mental diseases selected from the group consisting of posttraumatic stress disorder (PTSD), drug addiction, and phobia.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: September 16, 2014
    Assignee: SNU R&DB Foundation
    Inventors: Sukwoo Choi, Sukwon Lee, Jeongyeon Kim, Beomjong Song, Ingie Hong, Sungmo Park, Jihye Kim, Junuk Lee, Bobae An, Kisoon Shin, Kyungjoon Park
  • PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES
    Publication number: 20110105622
    Abstract: A pharmaceutical composition, comprising a GluR2-lacking AMPAR antagonist as an active ingredient, is effective for preventing or treating mental diseases selected from the group consisting of posttraumatic stress disorder (PTSD), drug addiction, and phobia.
    Type: Application
    Filed: February 12, 2009
    Publication date: May 5, 2011
    Applicant: SNU R&DB FOUNDATION
    Inventors: Sukwoo Choi, Sukwon Lee, Jeongyeon Kim, Beomjong Song, Ingie Hong, Sungmo Park, Jihye Kim, Junuk Lee, Bobae An, Kisoon Shin, Kyungjoon Park